↓
 

Tag Archives: molecular oncology

Dr. Jack West: Exploring and Explaining the Shortcomings in Molecular Testing and Execution of Targeted Therapy

Host Jack West reviews the gulf between the best evidence-based cancer care guidelines & performance in broad clinical practice, exploring contributing factors & potential new models to improve US-based molecular oncology practice. (23:09)

Dr. Benjamin Besse: National Collaboration Throughout France to Accelerate Precision Medicine Research in Cancer Care

Dr. Benjamin Besse, Head of Medical Oncology at Institut Gustave Roussy, reviews his path into oncology & describes how strong national programs & a collaborative oncology community conduct translational research together across France. (24:50)

Ishwaria & Vivek Subbiah (Part 2): Integrating Novel Treatments and Supportive Care in a Tertiary Care Referral Center

Drs. Ishwaria & Vivek Subbiah of MD Anderson Cancer Center review the challenges of weaving supportive care & symptom management with emerging targeted therapies & other novel treatments to blend into optimal cancer care. (29:10)

Dr. Sandip Patel (Pt 2): Advances and Impasses in Precision Medicine for Cancer

Dr. Jack West speaks with Dr. Sandip Patel about how molecular oncology has changed outcomes in cancer care, but also how we face great difficulty in getting the knowledge & practice patterns out to communities. (31:49)

Dr. Ross Camidge (Pt 2): NCCN Guidelines, New Research Initiatives, & Partnering with Patient Groups

Dr. West speaks with Dr. Ross Camidge about the experience of contributing to the NCCN guidelines, developing the ATOMIC network as a novel platform for lung cancer research, & the increasing importance of online patient molecularly defined groups. (10:25)

Dr. Ross Camidge (Pt 1): Working at the Forefront of Developing New Targets and New Therapies

Dr. Ross Camidge from the University of Colorado discusses his career trajectory, how cancer research in narrow molecularly defined populations has evolved, challenges in molecular oncology practice, & the brain as a new frontier for treatment efficacy. (24:40)

Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (24:32)

Genomic Sequencing for All Solid Tumors: Where Will This Lead Us? (BMIC-019)

Dr. Jack West reviews the implications, both encouraging and potentially detrimental, of a recent FDA approval for broad genomic (NGS) testing of all solid tumors, ushering in a new era of growing precision medicine and molecular oncology. (8:55)

Download MP3 Audio Version

↑